SPARC (secreted protein acidic and rich in cysteine) knockdown protects mice from acute liver injury by reducing vascular endothelial cell damage

被引:0
作者
E Peixoto
C Atorrasagasti
J B Aquino
R Militello
J Bayo
E Fiore
F Piccioni
E Salvatierra
L Alaniz
M G García
R Bataller
F Corrales
M Gidekel
O Podhajcer
M I Colombo
G Mazzolini
机构
[1] Liver Unit,
[2] Gene Therapy Laboratory,undefined
[3] Facultad de Ciencias Biomédicas,undefined
[4] Universidad Austral,undefined
[5] CONICET (Consejo Nacional de Investigaciones Científicas y Técnicas),undefined
[6] Buenos Aires,undefined
[7] Argentina,undefined
[8] Facultad de Ciencias Médicas,undefined
[9] Universidad Nacional de Cuyo,undefined
[10] Molecular and Cellular Therapy Laboratory,undefined
[11] Fundación Instituto Leloir,undefined
[12] University of North Carolina at Chapel Hill,undefined
[13] Chapel Hill,undefined
[14] NC,undefined
[15] USA,undefined
[16] Institut d’Investigacions Biomediques August Pi i Sunyer (IDIBAPS),undefined
[17] Barcelona,undefined
[18] Spain,undefined
[19] CIMA,undefined
[20] Universidad de Navarra,undefined
[21] Pamplona,undefined
[22] España,undefined
[23] Universidad de la Frontera,undefined
[24] Temuco,undefined
[25] Chile.,undefined
[26] Universidad Autónoma de Chile,undefined
[27] Santiago,undefined
[28] Chile,undefined
来源
Gene Therapy | 2015年 / 22卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Secreted protein, acidic and rich in cysteine (SPARC) is involved in many biological process including liver fibrogenesis, but its role in acute liver damage is unknown. To examine the role of SPARC in acute liver injury, we used SPARC knock-out (SPARC−/−) mice. Two models of acute liver damage were used: concanavalin A (Con A) and the agonistic anti-CD95 antibody Jo2. SPARC expression levels were analyzed in liver samples from patients with acute-on-chronic alcoholic hepatitis (AH). SPARC expression is increased on acute-on-chronic AH patients. Knockdown of SPARC decreased hepatic damage in the two models of liver injury. SPARC−/− mice showed a marked reduction in Con A-induced necroinflammation. Infiltration by CD4+ T cells, expression of tumor necrosis factor-α and interleukin-6 and apoptosis were attenuated in SPARC−/− mice. Sinusoidal endothelial cell monolayer was preserved and was less activated in Con A-treated SPARC−/− mice. SPARC knockdown reduced Con A-induced autophagy of cultured human microvascular endothelial cells (HMEC-1). Hepatic transcriptome analysis revealed several gene networks that may have a role in the attenuated liver damaged found in Con A-treated SPARC−/− mice. SPARC has a significant role in the development of Con A-induced severe liver injury. These results suggest that SPARC could represent a therapeutic target in acute liver injury.
引用
收藏
页码:9 / 19
页数:10
相关论文
共 162 条
[1]  
Bernuau J(1986)Fulminant and subfulminant liver failure: definitions and causes Semin Liver Dis 6 97-106
[2]  
Rueff B(2000)SPARC, a matricellular protein: at the crossroads of cell-matrix Matrix Biol 19 569-580
[3]  
Benhamou JP(2001)SPARC, a matricellular protein that functions in cellular differentiation and tissue response to injury J Clin Invest 107 1049-1054
[4]  
Brekken RA(2013)Lack of the matricellular protein SPARC (secreted protein, acidic and rich in cysteine) attenuates liver fibrogenesis in mice PLoS One 8 e54962-32152
[5]  
Sage EH(1999)SPARC regulates the expression of collagen type I and transforming growth factor-beta1 in mesangial cells J Biol Chem 274 32145-657
[6]  
Bradshaw AD(1997)Osteonectin (SPARC) expression in human liver and in cultured human liver myofibroblasts Am J Pathol 151 651-756
[7]  
Sage EH(2007)SPARC is a VCAM-1 counter-ligand that mediates leukocyte transmigration J Leukoc Biol 81 748-350
[8]  
Atorrasagasti C(1995)SPARC mediates focal adhesion disassembly in endothelial cells through a follistatin-like region and the Ca(2+)-binding EF-hand J Cell Biochem 57 341-203
[9]  
Peixoto E(1992)A T cell-dependent experimental liver injury in mice inducible by concanavalin A J Clin Invest 90 196-826
[10]  
Aquino JB(2008)Autophagy induction in T cell-independent acute hepatitis induced by concanavalin A in SCID/NOD mice Int J Immunopathol Pharmacol 21 817-670